Notice Regarding the Recording of a Gain on Sale of Investment Securities (Extraordinary Income)
MEDIPAL HOLDINGS CORPORATION (reporting company)
8 listed securities held by the company
Because the company reduced its strategic shareholdings in accordance with the Corporate Governance Code and the measures disclosed on 13 May 2025 in “Measures to Achieve Management That Is Conscious of Cost of Capital and Share Prices.”
Gain on sales of investment securities of ¥15,485 million (extraordinary income). Of this amount, ¥6,061 million was recorded in the consolidated accounting period for the first quarter of the fiscal year ending March 2027.
Consolidated accounting period for the first quarter of the fiscal year ending March 2027 (¥6,061 million)
For the impact on consolidated results for the fiscal year ending March 2027 and other matters arising from the gain on sales of investment securities (extraordinary income), see “Notice Regarding Revisions to Full-Year Consolidated Earnings Forecasts,” released today.
For the impact on consolidated results for the fiscal year ending March 2027 and other matters arising from the gain on sales of investment securities (extraordinary income), see “Notice Regarding Revisions to Full-Year Consolidated Earnings Forecasts,” released today.
| Item | Details |
|---|---|
| Event name | Notice Regarding the Recording of a Gain on Sale of Investment Securities (Extraordinary Income) |
| Date of occurrence | May–October 2026 (sale period) |
| Subject Entity | MEDIPAL HOLDINGS CORPORATION (reporting company) |
| Target Locations / Products | 8 listed securities held by the company |
| Cause | Because the company reduced its strategic shareholdings in accordance with the Corporate Governance Code and the measures disclosed on 13 May 2025 in “Measures to Achieve Management That Is Conscious of Cost of Capital and Share Prices.” |
| Amount of Impact on Business Performance | Gain on sales of investment securities of ¥15,485 million (extraordinary income). Of this amount, ¥6,061 million was recorded in the consolidated accounting period for the first quarter of the fiscal year ending March 2027. |
| Accounting period in which recognized | Consolidated accounting period for the first quarter of the fiscal year ending March 2027 (¥6,061 million) |
| Impact on Earnings Forecast | For the impact on consolidated results for the fiscal year ending March 2027 and other matters arising from the gain on sales of investment securities (extraordinary income), see “Notice Regarding Revisions to Full-Year Consolidated Earnings Forecasts,” released today. |
| Outlook | For the impact on consolidated results for the fiscal year ending March 2027 and other matters arising from the gain on sales of investment securities (extraordinary income), see “Notice Regarding Revisions to Full-Year Consolidated Earnings Forecasts,” released today. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because the company reduced its strategic shareholdings in accordance with the Corporate Governance Code and the measures disclosed on 13 May 2025 in “Measures to Achieve Management That Is Conscious of Cost of Capital and Share Prices.”